15 Grants
2021
A Novel Agent to Suppress Tumor Growth in Bone, Prevent Cachectic Muscle Loss and Preserve Skeletal Integrity
Chirgwin, John M and Suvannasankha, Attaya
National Institutes of Health (NIH), Veterans Affairs (VA) (ID: 5I01BX004514-03), 2019-04-01 -- 2023-03-31
2020
A Novel Agent to Suppress Tumor Growth in Bone, Prevent Cachectic Muscle Loss and Preserve Skeletal Integrity
Chirgwin, John M and Suvannasankha, Attaya
National Institutes of Health (NIH), Veterans Affairs (VA) (ID: 5I01BX004514-02), 2019-04-01 -- 2023-03-31
2019
A Novel Agent to Suppress Tumor Growth in Bone, Prevent Cachectic Muscle Loss and Preserve Skeletal Integrity
Chirgwin, John M and Suvannasankha, Attaya
National Institutes of Health (NIH), Veterans Affairs (VA) (ID: 1I01BX004514-01A1), 04/01/2019 -- 03/31/2023
2017
Role of Osteocytes in Myeloma Bone Disease
Chirgwin, John M and Suvannasankha, Attaya
National Institutes of Health (NIH), Veterans Affairs (VA) (ID: 5I01CX000977-04), 07/01/2014 -- 06/30/2018
2016
Role of Osteocytes in Myeloma Bone Disease
Chirgwin, John M and Suvannasankha, Attaya
National Institutes of Health (NIH), Veterans Affairs (VA) (ID: 5I01CX000977-03), 07/01/2014 -- 06/30/2018
2015
Role of Osteocytes in Myeloma Bone Disease
Chirgwin, John M and Suvannasankha, Attaya
National Institutes of Health (NIH), Veterans Affairs (VA) (ID: 5I01CX000977-02), 07/01/2014 -- 06/30/2018
2014
Role of Osteocytes in Myeloma Bone Disease
Chirgwin, John M and Suvannasankha, Attaya
National Institutes of Health (NIH), Veterans Affairs (VA) (ID: 1I01CX000977-01A1), 07/01/2014 -- 06/30/2018
2002
PSA Converts Parathyroid Hormone-Related Protein (PTHrP) from an Osteolytic Factor to an Osteoblastic One: Role in Bone Metastasis
Chirgwin, John C
Us Army Prostate Cancer Program Idea Award #Pc010497, $373,779/$540,110, Jan 1, 2002 -- Dec 31, 2004
 
Tumor-Secreted Autocrine Motility [AMF]: Causal Role in an Animal Model of Cachexia
Chirgwin, John C
Us Army Breast Cancer Program Idea Award, $206,031/$300,299, Mar 1, 2002 -- Feb 28, 2004
2001
Breast Cancer Osteolysis: PTHrP Regulation by TGF-beta
Chirgwin, John C
NATIONAL INSTITUTES OF HEALTH (NIH), $870,000/$1,271,500, Apr 1, 2001 -- Mar 31, 2006
1999
Effects of Tumors on the Skeleton'Role of Bone-Derived IGFs in Bone metastasis of Human Breast Cancer'
Chirgwin, John C
NATIONAL INSTITUTES OF HEALTH (NIH), $4,051,101, Jul 1, 1999 -- Jun 30, 2004
 
Role of Bone-Derived TGF-beta in Skeletal Metastases
Chirgwin, John C
Va Merit Award, $796,000/$796,000, Oct 1, 1999 -- Sep 30, 2004
1992
GENE EXPRESSION DURING OSTEOCLAST DIFFERENTIATION
Chirgwin, John M
National Institutes of Health (NIH), National Institute of Arthritis and Muscoloskeletal and Skin Diseases (NIAMS) (ID: 5P01AR039529-03-0002), 1992
1991
GENE EXPRESSION DURING OSTEOCLAST DIFFERENTIATION
Chirgwin, John M
National Institutes of Health (NIH), National Institute of Arthritis and Muscoloskeletal and Skin Diseases (NIAMS) (ID: 5P01AR039529-02-0002), 1991
1990
GENE EXPRESSION DURING OSTEOCLAST DIFFERENTIATION
Chirgwin, John M
National Institutes of Health (NIH), National Institute of Arthritis and Muscoloskeletal and Skin Diseases (NIAMS) (ID: 1P01AR039529-01A1-0002), 1990